Form 8.3 - Pfizer Inc


FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) State Street Global Advisors & Affiliates
Company dealt in Pfizer Inc
Class of relevant security to which
the dealings being disclosed relate
(Note 2)
US$0.05 common stock
Date of dealing 06th Nov 2015

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

  Long Short
  Number (%) Number (%)
(1) Relevant securities 308,396,794 4.99617%    
(2) Derivatives (other than options) N/A      
(3) Options and agreements to
purchase/sell
N/A      
Total 308,396,794 4.99617%    

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
  Number (%) Number (%)
(1) Relevant securities N/A      
(2) Derivatives (other than options) N/A      
(3) Options and agreements to purchase/sell N/A      
Total N/A      

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit (Note 5)
Purchase  300 33.93
Purchase  1,100 33.93
Purchase  1,661 33.93
Purchase  11,200 33.93
Purchase  33,000 33.93
Purchase  400 33.93
Purchase  4,400 33.93
Purchase  30 33.69
Purchase  60 33.75
Purchase  209,580 33.93
Purchase  306,820 33.93
Purchase  114,730 33.93
Purchase  3,300 33.93
Purchase  600 33.39
Purchase  1,800 33.93
Sale  81,950 33.93
Sale  11,200 33.93
Sale  400 33.93
Sale  80,700 33.93
Sale  4,400 33.93
Sale  300 33.93
Sale  600 33.92

 (b) Derivatives transactions (other than options transactions)

Product name,
e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)
N/A      

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,
e.g. call option
Writing, selling,
purchasing
 varying etc.
Number of
securities to which
the option relates
(Note 7)
Exercise
price
Type, e.g.
American,
European etc.
Expiry
date
Option money
paid/received
per unit
(Note 5)
N/A            

(ii) Exercising

Product name,
e.g. call option
Number of securities Exercise price per
unit
(Note 5)
N/A    

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction
(Note 8)
Details Price per unit
(if applicable)
(Note 5)
N/A    

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
N/A

Is a Supplemental Form 8 attached? (Note 9) NO


Date of disclosure 09th Nov 2015
Contact name Chetan Shah
Telephone number +(44) 20 3395 6564

 
If a connected EFM, name of offeree/offeror with which connected N/A
If a connected EFM, state nature of connection (Note 10) N/A
GlobeNewswire

Recommended Reading